Antibiotic Resistance in COPD Patients in the Intensive Care Unit: A Review of Recent Developments
Author:
Open Access
- 31 January 2025
- journal article
- review article
- Published by New Trends in Medicine Sciences in New Trends in Medicine Sciences
- Vol. 6 (1) , 22-25
Abstract
Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality globally, and it remains a leading contributor to hospital admissions, particularly in the elderly. In the past decade, COPD has been identified as one of the leading risk factors for infection-related complications, including pneumonia, bronchitis, and ventilator-associated pneumonia (VAP). Antibiotics are a cornerstone of therapy for COPD exacerbations caused by bacterial infections. However, inappropriate antibiotic use in this patient population has led to an increasing burden of antibiotic resistance. The overuse of broad-spectrum antibiotics is especially problematic in ICU settings, where empirical antibiotic treatment is often initiated without adequate microbiological testing. The relationship between COPD and antibiotic resistance is multifaceted. On the one hand, COPD patients are more likely to require antibiotics due to recurrent infections, leading to frequent antibiotic courses. On the other hand, the repeated exposure to antibiotics can promote the selection of resistant bacterial strains. The management of antibiotic resistance in COPD patients, particularly those in the ICU, is a complex and growing challenge. Strategies such as antibiotic stewardship programs, rapid microbiological diagnostics, and the use of narrow-spectrum antibiotics have been shown to reduce the emergence of resistant organisms and improve patient outcomes. However, the problem of antibiotic resistance in COPD patients remains significant, particularly in the context of multidrug-resistant pathogens.Keywords
This publication has 12 references indexed in Scilit:
- Synergistic effects of COVID-19 and Pseudomonas aeruginosa in chronic obstructive pulmonary disease: a polymicrobial perspectiveMolecular and Cellular Biochemistry, 2023
- Antimicrobial Stewardship Program for Patients in the Hematological Department Receiving Carbapenem Therapy: A Single-Center and Interrupted Time Series AnalysisAntibiotics, 2023
- Trends in the Bacterial Prevalence and Antibiotic Resistance Patterns in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Hospitalized Patients in South IndiaAntibiotics, 2022
- Vaccination and modern management of chronic obstructive pulmonary disease – a narrative reviewExpert Review of Respiratory Medicine, 2022
- Novel Immunomodulatory Therapies for Respiratory Pathologies2022
- Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impactRespirology, 2021
- Ventilator-associated pneumonia in adults: a narrative reviewIntensive Care Medicine, 2020
- Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)Cochrane Database of Systematic Reviews, 2018
- Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortalityBMC Infectious Diseases, 2017
- Multiple-drug–resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome*Critical Care Medicine, 2006